Cizzle Biotechnology Holdings Stock Fundamentals
| CIZ Stock | 1.90 0.20 11.76% |
Cizzle Biotechnology Holdings fundamentals help investors to digest information that contributes to Cizzle Biotechnology's financial success or failures. It also enables traders to predict the movement of Cizzle Stock. The fundamental analysis module provides a way to measure Cizzle Biotechnology's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cizzle Biotechnology stock.
At present, Cizzle Biotechnology's Net Interest Income is projected to increase significantly based on the last few years of reporting. Cizzle | Select Account or Indicator |
Cizzle Biotechnology Holdings Company Shares Outstanding Analysis
Cizzle Biotechnology's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Cizzle Biotechnology Shares Outstanding | 396.39 M |
Most of Cizzle Biotechnology's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cizzle Biotechnology Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Cizzle Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, Cizzle Biotechnology Holdings has 396.39 M of shares currently outstending. This is 119.57% higher than that of the Biotechnology sector and 270.96% higher than that of the Health Care industry. The shares outstanding for all United Kingdom stocks is 30.68% higher than that of the company.
Cizzle Biotechnology Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cizzle Biotechnology's current stock value. Our valuation model uses many indicators to compare Cizzle Biotechnology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cizzle Biotechnology competition to find correlations between indicators driving Cizzle Biotechnology's intrinsic value. More Info.Cizzle Biotechnology Holdings is rated second in return on equity category among its peers. It is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cizzle Biotechnology's earnings, one of the primary drivers of an investment's value.Cizzle Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cizzle Biotechnology's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cizzle Biotechnology could also be used in its relative valuation, which is a method of valuing Cizzle Biotechnology by comparing valuation metrics of similar companies.Cizzle Biotechnology is currently under evaluation in shares outstanding category among its peers.
Cizzle Fundamentals
| Return On Equity | -1.58 | ||||
| Return On Asset | -0.32 | ||||
| Current Valuation | 5.92 M | ||||
| Shares Outstanding | 396.39 M | ||||
| Shares Owned By Insiders | 43.65 % | ||||
| Price To Book | 8.49 X | ||||
| Price To Sales | 200.48 X | ||||
| Gross Profit | 25 K | ||||
| EBITDA | (695) | ||||
| Net Income | (1.76 M) | ||||
| Total Debt | 186 K | ||||
| Book Value Per Share | 0 X | ||||
| Cash Flow From Operations | (639 K) | ||||
| Earnings Per Share | (0.01) X | ||||
| Beta | 0.37 | ||||
| Market Capitalization | 7.53 M | ||||
| Total Asset | 1.69 M | ||||
| Retained Earnings | (7.87 M) | ||||
| Working Capital | 1.51 M | ||||
| Net Asset | 1.69 M |
About Cizzle Biotechnology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cizzle Biotechnology Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cizzle Biotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cizzle Biotechnology Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | (11.50) | (12.07) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Cizzle Stock
Cizzle Biotechnology financial ratios help investors to determine whether Cizzle Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cizzle with respect to the benefits of owning Cizzle Biotechnology security.